Electrical stimulation and gene-based neuromodulation for control of medically-refractory epilepsy
- 1 January 2007
- book chapter
- Published by Springer Nature
- Vol. 97, 293-309
Abstract
The failure of available antiepileptic medications to adequately control seizures in a substantial number of patients underscores the need to develop novel epilepsy therapies. Recent advancements in technology and the success of neuromodulation in treating a variety of neurological disorders have spurred interest in exploring promising therapeutic alternatives, such as electrical stimulation and gene-based synaptic control. A variety of different stimulation approaches to seizure control targeting structures in the central or peripheral nervous system have been investigated. Most studies have been based on uncontrolled observations and empirical stimulation protocols. Today the vagus nerve stimulator is the only FDA approved adjunctive treatment for epilepsy that utilizes electrical stimulation. Other potential strategies including direct stimulation of the epileptogenic cortex and deep brain stimulation of various targets are currently under investigation. Chronically implanted devices for electrical stimulation have a variety of limitations. First, they are susceptible to malfunction and infection. Second, most systems require battery replacement. Finally, electrical stimulation is incapable of manipulating neuronal function in a transmitter specific fashion. Gene delivery to epileptogenic targets or targets implicated in regulating seizure threshold has been investigated as an alternative means of neuromodulation in animal models. In summary, positive preliminary results and the lack of alternative treatment options provide the impetus for further exploration of electrical stimulation and gene-based therapies in pharmacoresistant epilepsy. Various specific targets and approaches to modulating their activity have been investigated in human studies.Keywords
This publication has 55 references indexed in Scilit:
- Double‐blind, Randomized Controlled Pilot Study of Bilateral Cerebellar Stimulation for Treatment of Intractable Motor SeizuresEpilepsia, 2005
- 433. Gene Therapy of Epilepsy by Adenovirus-Mediated Tetanus Toxin Light Chain Gene TransferMolecular Therapy, 2005
- Focal treatment for refractory epilepsy: hope for the future?Brain Research Reviews, 2004
- The Mechanism of Action of Vagus Nerve Stimulation for Refractory EpilepsyJournal Of Clinical Neurophysiology, 2001
- Effects of Therapeutic Stimulation of Nucleus caudatus on Epileptic Electrical Activity of Brain in Patients with Intractable EpilepsyStereotactic and Functional Neurosurgery, 1997
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993
- Evoked Metabolic Responses in the LimbicStriate System Produced by Stimulation of Anterior Thalamic Nucleus in ManPacing and Clinical Electrophysiology, 1987
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- A double-blind trial of chronic cerebellar stimulation in twelve patients with severe epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Preliminary evaluation of cerebellar stimulation by double-blind stimulation and biological criteria in the treatment of epilepsyJournal of Neurosurgery, 1978